US M&A and equity raisings

3,392 deals since January 2025, with sources and adviser credits where available · as at 20 Nov 2026 · Venture rounds

Deals dated after 30 September 2026 are still being collected.

Deal size
Custom range

58 deals · US$48bndisclosed · Life Sciences · Clear

Columns
US M&A deals and equity raisings
Date Target Vendor Acquirer Type Status Value US$m Sector Advisers
Dec 2025 Generation Bio Co. –XRA 7 Corp.AcquisitionAnnounced–Biotech+1 TD Securities (sell-side)WilmerHale (sell-side)Gibson Dunn (buy-side)
Dec 2025 Freenome Holdings –Perceptive Capital Solutions CorpMergerCompleted725.0Diagnostics+2 TD Securities (sell-side)Guggenheim Securities (sell-side)BTIG (sell-side)Goodwin (sell-side)Greenberg Traurig (sell-side)Richards, Layton & Finger (sell-side)H.C. Wainwright & Co. (sell-side)Jefferies (buy-side)Leerink Partners (buy-side)Cooley (buy-side)Ropes & Gray (buy-side)Maples Group (buy-side)Ogier (buy-side)Scalar (buy-side)
Oct 2025 SWK Holdings –Runway Growth Finance Corp.AcquisitionCompleted249.0Financial Services+1 Keefe, Bruyette & Woods (sell-side)Goodwin (sell-side)Kroll (sell-side)Simpson Thacher & Bartlett (buy-side)Dechert (buy-side)
Jul 2025 BD Biosciences & Diagnostic Solutions business Becton, Dickinson and CompanyWatersAsset saleCompleted18,800.0Life Sciences+2 Citi (sell-side)Evercore (sell-side)Wachtell, Lipton, Rosen & Katz (sell-side)Skadden, Arps, Slate, Meagher & Flom (sell-side)Barclays (buy-side)Kirkland & Ellis (buy-side)
Feb 2025 Mayne Pharma Group –Cosette PharmaceuticalsSchemeWithdrawn417.9Healthcare+1 Jefferies (sell-side)Gilbert + Tobin (sell-side)Arnold & Porter (sell-side)Davis Wright Tremaine (sell-side)EY (sell-side)Deloitte (sell-side)Santander (buy-side)UBS (buy-side)Corrs Chambers Westgarth (buy-side)Ropes & Gray (buy-side)
Feb 2025 AdvanCell –SV Health InvestorsStakeCompleted–Healthcare+1 Johnson Winter Slattery (buy-side)Honigman (buy-side)
Jan 2025 ImaginAb therapeutic candidates, biologics technology platform and research facility ImaginAbTelix PharmaceuticalsAsset saleCompleted45.0Healthcare+1 Jefferies (sell-side)Stifel (sell-side)
Apr 2024 Model N –Vista Equity PartnersAcquisitionCompleted1,250.0Vertical SaaS+1 Jefferies (sell-side)Fenwick & West (sell-side)Kirkland & Ellis (buy-side)William Blair (buy-side)

Deals come from SEC filings (merger proxies, tender offers, 8-K announcements and IPO prospectuses), the deal pages and transaction lists of law firms and banks, companies' press releases and the press. How the data is built